Industry Analysis & Industry Trends
Sustained increases in health expenditure, rising disposable income and an aging population have underpinned growth over the past five years. Revenue is projected expand during the next five years, with health expenditure and per capita disposable income continuing to rise. As a result, a greater number of companies are likely to enter the industry. However, competition from alternative retailers will remain a threat, despite this expansion... purchase to read more
Industry Report - Industry Products Chapter
Pharmacies and drug stores have benefited from pharmaceuticals being one of the fastest growing components of healthcare spending in Canada, with pharmaceutical expenditures accounting for a slightly lower share of total healthcare spending, compared with hospital expenditures.
Branded prescription drugs
In 2016, branded prescription drugs are expected to account for the largest share of industry revenue, with an estimated 44.3% of industry revenue. According to IMS Health, the average cost of a brand-name prescription is $76.05, which has steadily increased at an annualized rate of 37.0% over the past ten years. As the Canadian population aged, more consumers demanded brand-name, cholesterol-lowering drugs... purchase to read more